| Q47102257 | A case of napsin A-positive metastatic lung cancer originating from the colon |
| Q44411766 | A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens |
| Q90671775 | Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer |
| Q33851540 | Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers |
| Q36502148 | Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature |
| Q50530754 | Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. |
| Q82664051 | Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer |
| Q36498167 | IMP3 can predict aggressive behaviour of lung adenocarcinoma |
| Q46090804 | Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer |
| Q38286457 | Identification of prostate cancer biomarkers in urinary exosomes |
| Q51547379 | Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. |
| Q46190356 | Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer |
| Q80629571 | Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions |
| Q50474123 | Napsin A is a specific marker for ovarian clear cell adenocarcinoma. |
| Q47137585 | Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma |
| Q51643436 | Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. |
| Q40157407 | Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation |
| Q90221983 | Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT |
| Q53655893 | Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes. |
| Q84780528 | Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: A report of the second case negative for cytokeratin 7 |
| Q34558896 | RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin. |
| Q50960534 | Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1. |
| Q47784240 | Surfactant protein A detection in primary pulmonary adenocarcinoma without bronchioloalveolar pattern |
| Q40025080 | The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity |
| Q34410117 | The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D. |
| Q41732728 | The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment |
| Q35202946 | The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis |
| Q33689655 | The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas |
| Q38937135 | Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology |
| Q36216878 | Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma |